Charles Grob
{{Short description|American psychiatrist, professor, and researcher}}
{{Use mdy dates|date=January 2025}}
Charles S. Grob is a professor of psychiatry and biobehavioral sciences and pediatrics and director of the Division of Child and Adolescent Psychiatry at Harbor–UCLA Medical Center.{{Cite web|url=http://www.harboruclapsych.com/charles-s-grob-m-d/|title=Charles S. Grob, M.D. |publisher=Harbor-UCLA Psychiatry|access-date=July 22, 2018|archive-url=https://web.archive.org/web/20180722184729/http://www.harboruclapsych.com/charles-s-grob-m-d/|archive-date=July 22, 2018|url-status=dead}} He received his two BS degrees from Oberlin College and Columbia University, before getting an MD from the State University of New York, Downstate Medical Center. Grob's research interests include anxiety and mood disorders and also self-medication and substance abuse. The FDA approved one of his Phase 1 studies to study the psychological and physiological effects of MDMA and the hallucinogen ayahuasca.Walsh RedGrob CSed Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics. Albany State University of New York2005;{{cite book |last=Grob |first=CS |chapter=11. The use of psilocybin in patients with advanced cancer and existential anxiety |editor-last1=Winkelman |editor-first1=MJ |editor-last2=Roberts |editor-first2=TB |title=Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatment |location=Westport, Conn. |publisher=Praeger |year=2007 |pages=205–216 |url=http://www.csam-asam.org/sites/default/files/pdf/misc/Grob_Article.pdf |archive-url=https://web.archive.org/web/20161024025048/http://www.csam-asam.org/sites/default/files/pdf/misc/Grob_Article.pdf |archive-date=October 24, 2016 |url-status=dead}}{{cite web|url=http://labiomed.org/charles-grob-md|title=Charles Grob, MD |publisher=LA BioMed}}{{cite web|url=https://psychedelicsalon.com/transcripts/charles-s-grob-m-d-psychedelic-researcher/|title=Charles S. Grob, M.D. – psychedelic researcher |publisher=Psychedelic Salon Podcasts}}
Grob is also the editor of Hallucinogens: A Reader, originally published in 2002. The book is a collection of psychedelic texts covering a wide range of topics, such as shamanism, society, and psilocybin research. It contains excerpts from figureheads of the psychedelic movement, including Terrence McKenna, Albert Hofmann, and Ralph Metzner.{{cite web|url=http://psypressuk.com/2010/03/09/literary-review-hallucinogens-a-reader-edit-charles-s-grob/|title=Hallucinogens A Reader by Charles S. Grob (Ed) |date=March 9, 2010|publisher=PsypressUK}}Grob CSed Hallucinogens: A Reader. New York: Tarcher/Putnam2002
Research projects
- The Hoasca Project – Hoasca, also known as ayahuasca, is a plant-based beverage used as a component of ritualistic practices in Brazil by the members of UDV, a syncretic religious movement. It is the most comprehensive and in-depth study done on the relationship between ayahuasca and mental health.{{cite web|url=https://myayahuasca.wordpress.com/the-hoasca-project/|title=The Hoasca Project|date=March 28, 2013}}{{cite web|url=http://www.maps.org/news-letters/v05n4/05404aya.html|title=MAPS - Volume 5 Number 4 Summer 1995 - The Hoasca Project: Current Status|publisher=}}{{cite web|url=https://www.youtube.com/watch?v=Q4XL_Hk_L5g|title=Dr. Charles Grob- Ayahuasca & Hallucinogens- Clinical studies- Past Present and Future|last=((MilagrosL7)) |date=March 12, 2011|publisher=|via=YouTube}}
- Psilocybin – Charles Grob conducted a study that observed the effect of psilocybin when used by patients with advanced cancer and existential anxiety. From 2004 to 2008, the research group at Harbor–UCLA Medical Center conducted a double-blind, placebo-controlled investigation examining the safety and efficacy of psilocybin as a treatment for advanced-cancer anxiety. A total of twelve subjects were studied, all of whom tolerated the experimental treatment without adverse effects.{{cite web|url=https://www.youtube.com/watch?v=tWeEp0S1AAQ|title=Psilocybin at the End of Life – Charles Grob|last=MAPS|date=July 24, 2013|publisher=|via=YouTube}} In August 2020, the Lundquist Institute announced Grob would co-lead a $1.75M+ study using psilocybin for palliative care of patients near the end of their lives.{{cite web |url=https://lundquist.org/news/lundquist-institute-accepts-175-million-anonymous-donation-improve-quality-dying | title=The Lundquist Institute Accepts a $1.75 Million Anonymous Donation to Improve the Quality of Dying | date=July 21, 2020 | publisher=The Lundquist Institute | access-date=January 7, 2025}}
See also
- {{annotated link|Psychedelia (film)|Psychedelia}}
References
{{Reflist}}
External links
- [https://www.erowid.org/culture/characters/grob_charles/grob_charles.shtml Charles S. Grob biography] at Erowid
{{Authority control}}
{{DEFAULTSORT:Grob, Charles}}
Category:Oberlin College alumni
Category:Columbia University alumni
Category:SUNY Downstate College of Medicine alumni
Category: David Geffen School of Medicine at UCLA faculty